Nav: Home

Some primary care doctors not prepared to help with cancer treatment decisions

February 12, 2019

ANN ARBOR, Michigan --The idea of team-based cancer care most often focuses on involving primary care physicians in the care of cancer survivors. But research has shown patients are discussing initial cancer treatment options with their primary care doctors.

And now a new study finds that a significant number of these physicians report notable gaps in their knowledge of cancer treatment options.

"Primary care physicians may be involved in cancer care earlier than we thought. If we are going to promote their involvement, we may need to start doing that earlier, around the time of initial treatment, and ensure PCPs have the information they need to effectively participate in the decision-making process," says Lauren P. Wallner, Ph.D., MPH, a health services researcher at the University of Michigan Rogel Cancer Center.

Wallner and colleagues from the Cancer Surveillance and Outcomes Research Team surveyed 517 primary care physicians who were linked to 1,077 women treated for early stage breast cancer. Physicians were asked whether they had discussed surgery, radiation or chemotherapy options with their patients. They were also asked how comfortable they were discussing these issues and whether they felt they had the knowledge to help with treatment decisions.

Researchers found that 34 percent of physicians had discussed surgery options with their patients, 23 percent had discussed radiation and 22 percent had discussed chemotherapy.

Physicians who reported more comfort with cancer treatment discussions were more likely to have these discussions. But, among those physicians who reported involvement in surgery decisions, 22 percent said they were not comfortable having that discussion and 17 percent said they did have the necessary knowledge. Similar findings played out for radiation and chemotherapy. Results are published in Cancer.

"We found that among those involved, some PCPs felt they did not have the knowledge necessary to participate in these treatment decisions. If they're going to be involved, we need to find a way to make sure they have the knowledge to do so and we support them in a way that ensures they're confident and able to do so," says Wallner, an assistant professor of general medicine and epidemiology at U-M.

The study follows up on a 2016 paper that found one-third of breast cancer patients said they consulted their primary care doctor about treatment options.

"We were all quite surprised that many patients said PCPs were involved. This work stems from those findings. We wanted to understand what decisions providers were involved with and how they perceived their involvement," Wallner says.

The study did not address what patients discussed or how detailed those discussions were. And as such, Wallner emphasizes that the nature of these conversations and how they influence treatment choices is not yet clear.

But, she says, helping patients better understand the risks and benefits of treatment options is a good thing. For patients who have a longstanding relationship with their primary care doctor, that physician may have a good grasp of the patient's values and preferences and may be able to help the patient navigate these decisions.

"This is an emerging challenge for primary care providers," Wallner says. "Inundating them with detailed information about all possible cancer treatments is not feasible. But these providers are likely to start becoming even more involved with the more prevalent cancers, such as breast or prostate cancer. They need to have sufficient resources and support to be prepared for these conversations."
-end-
Additional authors: Yun Li, Ph.D.; Chandler McLeod, Ph.D., M.S.; Joan Gargaro, MPH, MBA; Allison W. Kurian, M.D., M.Sc.; Reshma Jagsi, M.D., D.Phil.; Archana Radhakrishnan, M.D., MHS; Ann S. Hamilton, Ph.D., M.A.; Kevin C. Ward, Ph.D., MPH, CTR; Sarah T. Hawley, Ph.D., MPH; Steven J. Katz, M.D., MPH

Funding: National Cancer Institute grants P01CA163233, K07 CA201052; Rogel Cancer Center

Disclosure: None

Reference: Cancer, doi: 10.1002/cncr.31998, published online Feb. 1, 2019

Resources:
University of Michigan Rogel Cancer Center, http://www.rogelcancercenter.org
Michigan Health Lab, http://www.MichiganHealthLab.org
Michigan Medicine Cancer AnswerLine, 800-865-1125

Michigan Medicine - University of Michigan

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.